Skip to content

Observational Study on Inappropriate Therapies

Observational Study on Inappropriate Therapies After Replacement of ICDs

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04118803
Acronym
OSIRIS
Enrollment
881
Registered
2019-10-08
Start date
2020-01-31
Completion date
2025-05-30
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICD Replacement or Upgrade, Inappropriate Shocks From Implanted Defibrillator

Brief summary

The purpose of the study is to assess the incidence of inappropriate shocks at 2 years, in a population of patients undergoing a generator replacement (VR/DR/CRT) or upgrade from a previously implanted ICD (VR/DR)

Detailed description

All subjects will be included during an inclusion visit (within 7 days post generator replacement or upgrade), and followed up at a post replacement visit (1 - 6 months post replacement or upgrade), at 12, 18 and 24 months post replacement or upgrade. These follow-up visits will be performed in-clinic except for the 18 months post replacement or upgrade visit, which could be performed through device remote monitoring. Additional follow-ups can be performed at physician's discretion. Data on reportable adverse events will be collected throughout the study. All study data will be collected using an EDC system. All delivered anti-tachycardia therapies (shock or ATP) will be reviewed by an independent board of experts in order to evaluate appropriateness. The programming of the device parameters is at physician's discretion (suggested settings is slow VT monitoring zone 150 - 185 bpm with 30 cycles persistence, VT zone 185 - 230 bpm with 16 cycles persistence, remote monitoring activated).

Interventions

DEVICEICD replacement or upgrade

Currently, it is common for patients to survive beyond their initial prophylactic ICD generator. It is unclear whether further benefit related to inappropriate shocks or ATP is derived from long-term device therapy, particularly if there has been a change in the patient's cardiovascular condition.

Sponsors

MicroPort CRM
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Any subject that had an ICD/CRT-D replacement/upgrade according to the latest relevant clinical guidelines with a MicroPort CRM ICD / CRT-D for less than 7 days 2. Signed and dated the informed consent form

Exclusion criteria

1. RV lead replacement 2. Previous ICD/CRT-D inactivated or already explanted 3. Active myocarditis 4. Primary prevention for Arrhythmogenic Ventricular Cardiomyopathy, Ion channelopathies, Hypertrophic Cardiomyopathy and Infiltrative or Inherited Cardiomyopathy. 5. Heart transplant (done or on waiting list) or implanted with a ventricular assist device (VAD) 6. Already included in an Interventional study that could confound the results of this study 7. Inability to understand the purpose of the study or to meet follow-up visits as defined in the investigational plan 8. Minor age (\<18 years) or under guardianship or kept in detention 9. Ongoing drug or alcohol addiction or abuse which would interfere with the subject's ability to be compliant with the study. 10. Life expectancy less than 1 year 11. Pregnant or breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Incidence of inappropriate shocks2 years after replacement or upgradeThis endpoint will assess the incidence of inappropriate shocks, in a population of patients undergoing a generator replacement (VR/DR/CRT) or upgrade from a previously implanted ICD (VR/DR).

Countries

Austria, Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, Switzerland, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026